Our facilities

Our state-of-the-art R&D and manufacturing facility in Pune spans over 135,000 square feet and is home to pioneering bioprocess manufacturing techniques. This facility allows us to offer fully integrated services, from cell line development to fill and finish, across a wide range of therapeutic modalities. These capabilities enable us to explore various aspects of drug development, including disruptive treatments for challenging diseases and innovative areas like antibody-drug conjugates (ADC) and cell and gene therapies (CGT).

Enzene provides both microbial and mammalian manufacturing capabilities, with commercialized products from both verticals. Our facilities are designed to meet US FDA and EMA GMP standards. We offer six drug substance manufacturing suites capable of addressing both conventional (fed-batch) and continuous manufacturing, achieving capacities from 20L to 2000L and producing approximately 30kg of mAb per month. Drug substance manufacturing is supported by drug product fill and finish with fully automated filling of vials, prefilled syringes, and cartridges.

Our US site in New Jersey significantly increases our capacity on the East Coast.

This state-of-the-art facility will feature Good Manufacturing Practice (GMP)-compliant drug substance manufacturing capabilities, along with supporting facilities such as a quality control laboratory, development laboratory, warehouse and temperature-controlled storage.